Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Federico

Showing results (221-230 of 233) with videos related to

Pageof 24
Sort By:
Tumori|December 17, 2009
International collaborations in cancer control and the Third International Cancer Control CongressAndrea Micheli, Natalia Sanz, Faith Mwangi-Powell, et al.
Haematologica|March 24, 2022
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL studyAlejandro Martín García-Sancho, Monica Bellei, Miriam López-Parra, et al.
Blood|May 6, 2004
Follicular lymphoma international prognostic indexPhilippe Solal-Céligny, Pascal Roy, Philippe Colombat, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 18, 2017
Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United StatesEric D Hsi, Steven M Horwitz, Kenneth R Carson, et al.
Breast Cancer Research and Treatment|October 9, 2003
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutationPaolo Aretini, Emma D'Andrea, Barbara Pasini, et al.
Lancet (London, England)|December 24, 2019
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trialViola Poeschel, Gerhard Held, Marita Ziepert, et al.
Hemasphere|July 10, 2023
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER StudyLorenz Thurner, Marita Ziepert, Christian Berdel, et al.
Breast (Edinburgh, Scotland)|May 15, 2013
Consistency and inconsistency in testing biomarkers in breast cancer. A GRELL study in cut-off variability in the Romance language countriesEmanuele Crocetti, Adele Caldarella, Stefano Ferretti, et al.
Cancer Epidemiology|July 27, 2025
Prevalence and survival outcomes of adult T-cell leukemia/lymphoma in Latin America: A multicenter cohort study and recommendations to improve diagnosis and outcomesBryan Valcarcel, Henry Idrobo, Astrid Pavlovsky, et al.
JAMA Oncology|February 26, 2026
Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 MutationsAndrea Napolitano, Heikki Joensuu, Sara Rothschild, et al.
Pageof 24

Showing results (221-230 of 233) with videos related to

Sort By:
Pageof 24
Tumori|December 17, 2009
International collaborations in cancer control and the Third International Cancer Control CongressAndrea Micheli, Natalia Sanz, Faith Mwangi-Powell, et al.
Haematologica|March 24, 2022
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL studyAlejandro Martín García-Sancho, Monica Bellei, Miriam López-Parra, et al.
Blood|May 6, 2004
Follicular lymphoma international prognostic indexPhilippe Solal-Céligny, Pascal Roy, Philippe Colombat, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 18, 2017
Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United StatesEric D Hsi, Steven M Horwitz, Kenneth R Carson, et al.
Breast Cancer Research and Treatment|October 9, 2003
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutationPaolo Aretini, Emma D'Andrea, Barbara Pasini, et al.
Lancet (London, England)|December 24, 2019
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trialViola Poeschel, Gerhard Held, Marita Ziepert, et al.
Hemasphere|July 10, 2023
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER StudyLorenz Thurner, Marita Ziepert, Christian Berdel, et al.
Breast (Edinburgh, Scotland)|May 15, 2013
Consistency and inconsistency in testing biomarkers in breast cancer. A GRELL study in cut-off variability in the Romance language countriesEmanuele Crocetti, Adele Caldarella, Stefano Ferretti, et al.
Cancer Epidemiology|July 27, 2025
Prevalence and survival outcomes of adult T-cell leukemia/lymphoma in Latin America: A multicenter cohort study and recommendations to improve diagnosis and outcomesBryan Valcarcel, Henry Idrobo, Astrid Pavlovsky, et al.
JAMA Oncology|February 26, 2026
Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 MutationsAndrea Napolitano, Heikki Joensuu, Sara Rothschild, et al.
Pageof 24